TMED vs. TDVG
TMED (T. Rowe Price Health Care ETF) and TDVG (T. Rowe Price Dividend Growth ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund managed by T. Rowe Price, while TDVG is a Large Cap Growth Equities fund actively managed by T. Rowe Price. A 0.58 correlation means they provide meaningful diversification when combined. TMED charges 0.44%/yr vs 0.50%/yr for TDVG.
Performance
TMED vs. TDVG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMED achieves a 3.87% return, which is significantly lower than TDVG's 7.48% return.
TMED
- 1D
- 1.04%
- 1M
- 2.47%
- YTD
- 3.87%
- 6M
- 4.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TDVG
- 1D
- -0.19%
- 1M
- 3.06%
- YTD
- 7.48%
- 6M
- 7.57%
- 1Y
- 17.02%
- 3Y*
- 15.63%
- 5Y*
- 10.03%
- 10Y*
- —
TMED vs. TDVG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 3.87% | 18.92% |
TDVG T. Rowe Price Dividend Growth ETF | 7.48% | 8.02% |
Correlation
The correlation between TMED and TDVG is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025 | 0.58 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. TDVG — Risk / Return Rank
TMED
TDVG
TMED vs. TDVG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and T. Rowe Price Dividend Growth ETF (TDVG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | TDVG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.77 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.72 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.35 | 0.94 | +0.41 |
Drawdowns
TMED vs. TDVG - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum TDVG drawdown of -19.20%. Use the drawdown chart below to compare losses from any high point for TMED and TDVG.
Loading charts...
Drawdown Indicators
| TMED | TDVG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -19.20% | +8.09% |
Max Drawdown (1Y)Largest decline over 1 year | — | -7.24% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -14.02% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -19.20% | — |
Current DrawdownCurrent decline from peak | -2.75% | -0.19% | -2.56% |
Average DrawdownAverage peak-to-trough decline | -2.59% | -3.76% | +1.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.76% | — |
Volatility
TMED vs. TDVG - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | TDVG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 2.11% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 7.45% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.04% | 9.67% | +8.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.04% | 13.91% | +4.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.04% | 13.93% | +4.11% |
TMED vs. TDVG - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than TDVG's 0.50% expense ratio.
Dividends
TMED vs. TDVG - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.52%, less than TDVG's 0.98% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
TDVG T. Rowe Price Dividend Growth ETF | 0.98% | 1.00% | 1.06% | 1.31% | 1.15% | 0.80% | 0.40% |
TMED T. Rowe Price Health Care ETF | 0.52% | 0.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMED and TDVG have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.50% for TDVG.
TDVG has the higher dividend yield at 0.98%, compared with 0.52% for TMED.
TMED is categorized as Health & Biotech Equities, while TDVG is Large Cap Growth Equities. Their fees differ too: 0.44% for TMED and 0.50% for TDVG.
Find the right allocation for TMED and TDVG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer